Skip to main content

Advertisement

SpringerLink
Log in

The battle for sequencing supremacy

  • News Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Which companies are leading the pack in terms of market share of the sequencing sector? Michael Eisenstein reports.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rohde, H. et al. N. Engl. J. Med. 365, 718–724 (2011).

    Article  CAS  Google Scholar 

  2. Loman, N.J. et al. Nat. Biotechnol. 30, 434–439 (2012).

    Article  CAS  Google Scholar 

  3. Koren, S. et al. Nat. Biotechnol. 30, 693–700 (2012).

    Article  CAS  Google Scholar 

  4. Peters, B.A. et al. Nature 487, 190–195 (2012).

    Article  CAS  Google Scholar 

  5. Quail, M. et al. BMC Genomics 13, 341 (2012).

    Article  CAS  Google Scholar 

  6. Lam, H.Y. et al. Nat. Biotechnol. 30, 78–82 (2011).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Philadelphia

    Michael Eisenstein

Authors
  1. Michael Eisenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eisenstein, M. The battle for sequencing supremacy. Nat Biotechnol 30, 1023–1026 (2012). https://doi.org/10.1038/nbt.2412

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2412

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation